TP63 and B-cell chronic lymphocytic leukemia: The Tumor Protein P63 (TP63) related pathway in non-mutated samples is completely absent in mutated samples, which demonstrates the prognostic relation between TP63- related pathways and IGHV mutation status in CLL patients [184].